Blyth Battery Goes Live. NHOA Energy and Elecnor Commission the 477MWh Asset for Neoen in South Australia
NHOA Energy, a global leader in the design, delivery and servicing of utility-scale energy storage systems, announces the completion of construction and commissioning of Neoen’s 238.5 MW / 477 MWh Blyth Battery.
The project was delivered for Neoen and in partnership with Elecnor Australia. Completion was achieved on time, on budget and in compliance with performance requirements from AEMO and ElectraNet.
The Blyth Battery will help firm the output of Neoen’s Goyder South Stage 1 wind farm, enabling the supply of 70 MW of renewable baseload power to BHP, a global leader in resources, as well as offer other services to the national electricity market. This pioneering undertaking was project-financed by a pool of international lenders.
Blyth Battery benefits from NHOA Energy’s technical excellence and world-class project management. A dedicated team of highly-qualified service professionals will now take over the operations and maintenance of the battery under a long-term contract with Neoen, to guarantee its long-term availability and performance.
Blyth reaffirms NHOA Energy’s position in the Australian energy storage market and its commitment to the energy transition of the continent and the development of its cleantech value chain.
“Blyth Battery is a great example of Neoen’s continuing commitment to grid stability and reliability in South Australia. We are proud to lead the State’s battery storage market and are excited to start supporting BHP under our innovative renewable energy baseload contract. We appreciate the dedication from & close collaboration with the teams at NHOA Energy & Elecnor, whose work has been essential in helping us meet this project milestone.”, commented Jean-Christophe Cheylus, CEO of Neoen Australia.
“We fulfilled our performance commitment to Neoen and its lenders, on time and on budget. This is what matters, in a scenario where energy storage systems become the cornerstone of grid stability, security and an affordable and sustainable energy supply. The successful commissioning of Blyth Battery is a testament to the dedication and expertise of our team and partners, and to our ability to serve clients globally” commented Lucie Kanius-Dujardin, Global Managing Director of NHOA Energy.
For more information, visitwww.nhoa.energy
View source version on businesswire.com: https://www.businesswire.com/news/home/20250409339374/en/
Contacts
Press Office: Claudia Caracausi and Davide Bruzzese, Image Building, +39 02
89011300, nhoa@imagebuilding.it
Communications: Teresa Pogliani, +39 340 464 9719, media.relations@nhoa.energy
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom